METHOTREXATE LPF Drug Patent Profile
When do Methotrexate Lpf patents expire, and when can generic versions of Methotrexate Lpf launch?
Methotrexate Lpf is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in METHOTREXATE LPF is methotrexate sodium. There is one drug master file entry for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methotrexate Lpf
A generic version of METHOTREXATE LPF was approved as methotrexate sodium by HIKMA on September 16th, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METHOTREXATE LPF?
- What are the global sales for METHOTREXATE LPF?
- What is Average Wholesale Price for METHOTREXATE LPF?
Summary for METHOTREXATE LPF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 53 |
| Clinical Trials: | 2,236 |
| Patent Applications: | 3,190 |
| DailyMed Link: | METHOTREXATE LPF at DailyMed |
Recent Clinical Trials for METHOTREXATE LPF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fred Hutchinson Cancer Center | PHASE2 |
| Incyte Corporation | PHASE2 |
| USWM, LLC (dba US WorldMeds) | PHASE2 |
Pharmacology for METHOTREXATE LPF
| Drug Class | Folate Analog Metabolic Inhibitor |
| Mechanism of Action | Folic Acid Metabolism Inhibitors |
US Patents and Regulatory Information for METHOTREXATE LPF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | METHOTREXATE LPF | methotrexate sodium | INJECTABLE;INJECTION | 011719-007 | Mar 31, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
